HWPC(688799.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
HWPC
688799.SH
Hunan Warrant Pharmaceutical Co.,Ltd manufactures and sells pharmaceutical products in China. It offers medicines in the areas of digestive, respiratory, anti-infection, diabetes, cardiovascular, cerebrovascular, and other fields. The company also provides APIs and Intermediates. Hunan Warrant Pharmaceutical Co.,Ltd was founded in 2001 and is based in Changsha, China.
2.805 T
688799.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking35/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE11.40%B
    • Profit Margin15.00%A
    • Gross Margin57.28%B
  • Growth ScoreB
    • Revenue YoY8.45%B
    • Net Profit YoY53.94%B
    • Total Assets YoY31.14%A
    • Net Assets YoY10.73%B
  • Cash ScoreB
    • Cash Flow Margin148.13%B
    • OCF YoY8.45%B
  • Operating ScoreC
    • Turnover0.52C
  • Debt ScoreB
    • Gearing Ratio35.93%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%

    Wallstreetcn·
    SZ
    159892
    -0.71%
    SH
    516820
    -0.60%
    SZ
    159849
    -0.21%
    Wallstreetcn·
    SZ
    159892
    -0.71%
    SH
    516820
    -0.60%
    SZ
    159849
    -0.21%

    HWPC: The company’s benidipine hydrochloride tablets are expected to win the national centralized drug procurement bid

    Zhitong·
    SH
    688799
    -2.61%
    Zhitong·
    SH
    688799
    -2.61%

    HWPC: The subsidiary's raw materials drug has received the approval notice for the listing application

    Zhitong·
    SH
    688799
    -2.61%
    Zhitong·
    SH
    688799
    -2.61%

    HWPC: Obtained the drug registration certificate for Sodium Potassium Polyethylene Glycol

    Zhitong·
    SH
    688799
    -2.61%
    Zhitong·
    SH
    688799
    -2.61%

    HWPC withdraws the registration application for Arolol hydrochloride tablets

    Zhitong·
    SH
    688799
    -2.61%
    Zhitong·
    SH
    688799
    -2.61%
    © 2026 Longbridge｜Disclaimer